Literature DB >> 18505395

Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

C N Cornelissen1.   

Abstract

Gonorrhea is the second most commonly reported infectious disease in the USA, and incidence has been increasing in recent years. Antibiotic resistance among clinical isolates has reached a critical point at which the CDC currently recommends only a single class of antibiotic for treatment. These developments have hastened the search for a vaccine to protect against gonococcal infections. Vaccine efforts have been thwarted by the ability of the gonococcus to antigenically vary most surface structures. The transferrin-iron transport system is not subject to high-frequency phase or antigenic variation and is expressed by all pathogenic Neisseria. Vaccine formulations comprised of epitopes of the transferrin-binding proteins complexed with inactivated cholera toxin generated antibodies with potentially protective characteristics. These antigens, and others predicted from genome sequence data, could be developed into a vaccine that protects against neisserial infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505395      PMCID: PMC2657661          DOI: 10.2217/17460913.3.3.287

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  75 in total

1.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

2.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

3.  Neisseria gonorrhoeae requires expression of TonB and the putative transporter TdfF to replicate within cervical epithelial cells.

Authors:  Tracey A Hagen; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2006-10-13       Impact factor: 3.501

4.  The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro.

Authors:  Friederike Feldmann; Liisa Johanna Sorsa; Kirsten Hildinger; Sören Schubert
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

5.  Drug-resistant gonorrhoeae spread in the USA.

Authors:  Michael McCarthy
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

6.  Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.

Authors:  Hilda M Hernández; Mabel Figueredo; Nidia Garrido; Lizet Sánchez; Jorge Sarracent
Journal:  Int J Parasitol       Date:  2005-09-15       Impact factor: 3.981

7.  Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

Authors:  Jutamas Ngampasutadol; Sanjay Ram; Anna M Blom; Hanna Jarva; Ann E Jerse; Egil Lien; Jon Goguen; Sunita Gulati; Peter A Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

8.  Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.

Authors:  Gregory A Price; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.

Authors:  Kyle T Bernstein; Supriya D Mehta; Anne M Rompalo; Emily J Erbelding
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

10.  Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.

Authors:  Christopher E Thomas; Weiyan Zhu; Cornelius N Van Dam; Nancy L Davis; Robert E Johnston; P Frederick Sparling
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more
  18 in total

1.  Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.

Authors:  Devin R Cash; Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

2.  Conserved regions of gonococcal TbpB are critical for surface exposure and transferrin iron utilization.

Authors:  Karen L Ostberg; Amanda J DeRocco; Shreni D Mistry; Mary Kathryne Dickinson; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  The genes that encode the gonococcal transferrin binding proteins, TbpB and TbpA, are differentially regulated by MisR under iron-replete and iron-depleted conditions.

Authors:  Justin L Kandler; Rosuany Vélez Acevedo; Mary Kathryne Dickinson; Devin R Cash; William M Shafer; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2016-07-18       Impact factor: 3.501

4.  Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets.

Authors:  Ryszard A Zielke; Igor H Wierzbicki; Jacob V Weber; Philip R Gafken; Aleksandra E Sikora
Journal:  Mol Cell Proteomics       Date:  2014-03-08       Impact factor: 5.911

Review 5.  Subversion of nutritional immunity by the pathogenic Neisseriae.

Authors:  Cynthia Nau Cornelissen
Journal:  Pathog Dis       Date:  2018-02-01       Impact factor: 3.166

6.  Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.

Authors:  Michael W Russell
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

7.  Extracellular heme uptake and the challenges of bacterial cell membranes.

Authors:  Aaron D Smith; Angela Wilks
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

8.  Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.

Authors:  Ryszard A Zielke; Igor H Wierzbicki; Benjamin I Baarda; Philip R Gafken; Olusegun O Soge; King K Holmes; Ann E Jerse; Magnus Unemo; Aleksandra E Sikora
Journal:  Mol Cell Proteomics       Date:  2016-05-02       Impact factor: 5.911

9.  New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host.

Authors:  Yingru Liu; Brandon Feinen; Michael W Russell
Journal:  Front Microbiol       Date:  2011-03-22       Impact factor: 5.640

10.  Vaccines for gonorrhea: can we rise to the challenge?

Authors:  Weiyan Zhu; Ching-Ju Chen; Christopher E Thomas; James E Anderson; Ann E Jerse; P Frederick Sparling
Journal:  Front Microbiol       Date:  2011-06-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.